Categories AlphaGraphs, Earnings, LATEST, Technology
Trxade Health (MEDS) reports 6% growth in Q1 revenue; loss widens
Pharmaceutical services company Trxade Health Inc (NASDAQ: MEDS) Monday reported a wider net loss for the first quarter of 2022 despite a 6% increase in revenues. The top-line also beat analysts’ estimates.
First-quarter revenues increased 6% year-over-year to $3.2 million and came in above analysts’ estimates. The company added 339 registered members during the three-month period.
Trxade reported a net loss of $1 million or $0.12 per share for the first quarter, compared to a loss of $0.7 million or $0.08 per share in the year-ago quarter. The bottom line missed analysts’ estimates.
Check this space to read management/analysts’ comments on Trxade’s Q1 2022 results
Shares of Trxade closed Monday’s trading lower. The stock has lost about 41% so far this year.
Prior Performance
Most Popular
Key highlights from Nio’s (NIO) Q3 2024 earnings results
NIO Inc. (NYSE: NIO) reported its third quarter 2024 earnings results today. Total revenues were $2.66 billion, down 2.1% from the same period a year ago. Net loss attributable
Key takeaways from Walmart’s (WMT) Q3 2025 report
Over the years, Walmart Inc. (NYSE: WMT) has followed a successful business model focused on offering customers a unique shopping experience and the best prices. While the retail giant continues
What to look for when Macy’s (M) reports its Q3 2024 earnings results
Shares of Macy’s, Inc. (NYSE: M) remained red on Tuesday. The stock has dropped 14% over the past three months. The retailer is scheduled to report its third quarter 2024
